Author Topic: MS management challenges and opportunities--Q&A with Thomas Leist, MD  (Read 54 times)

0 Members and 0 Guests are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 9670
  • MS diagnosed 1980
  • Location: Pacific Northwest
From the American Journal of Managed Care (November 25, 2019)--"Multiple sclerosis management challenges and opportunities: A Q&A with Thomas Leist, MD, PhD":

Dr. Leist states:

Leist:[/size] It is probably the majority view that MS is a syndrome and not a single disease. The current emphasis on relapsing-remitting, secondary progressive, and primary progressive MS is limited by the fact that these are phenomenological and not biological categorizations.[/color]

That MS is not a single disease is an idea that has been suggested for many years. It is interesting that Dr. Leist regards it as the majority view that "MS is a syndrome and not a single disease."
MS Speaks--online for 17 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20.


Related Topics

  Subject / Started by Replies Last post
0 Replies
Last post April 01, 2016, 08:57:14 am
by agate
0 Replies
Last post May 22, 2016, 12:13:55 pm
by agate
0 Replies
Last post September 21, 2016, 10:41:56 am
by agate
0 Replies
Last post October 24, 2017, 02:40:13 pm
by agate
0 Replies
Last post February 05, 2023, 09:14:30 pm
by agate